Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Aug;21(8):476–488. doi: 10.1097/FPC.0b013e3283481967

Figure 3.

Figure 3

Correlation between slopes of apoptosis and percent survival curves. Slopes were calculated from survival and apoptosis curves with % survival or caspase activity against log transformed concentrations of (A) cytarabine, (B) paclitaxel, (C) carboplatin and (D) cisplatin.